Tuesday, October 08, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

NEWS

Latin America to use thermotherapy to treat cutaneous leishmaniasis

Washington, Dec 18 (Prensa Latina) With the support of the Pan American Health Organization (PAHO), Ecuador, Honduras, Nicaragua, and Venezuela have begun to implement new therapies to treat cutaneous leishmaniasis, a disease that affects around 42,000 people each year in Latin America and which can leave disfiguring scars.

Leishmaniasis is caused by parasites transmitted through the bite of infected female insects. In its most common form, cutaneous, it causes ulcers or nodules on the skin.

The disease is endemic in 18 countries of the Americas, with the poorest people in remote and hard-to-reach tropical areas most at risk.

Currently in the region, most patients with cutaneous leishmaniasis receive a systemic treatment. This traditional treatment, which has been in use for more than 70 years, consists of a series of intravenous injections for 20 days.

Despite its efficacy, the treatment can have side effects, such renal and hepatic function alteration or arrhythmia.

In September 2022, PAHO updated its guidelines for the treatment of leishmaniasis, which include localized therapy to treat cutaneous cases with the drug meglumine antimoniate, as well as the use of thermotherapy.

Thermotherapy generates high-frequency waves that are applied locally over the lesion at a temperature of 50º Celsius for a period of 30 seconds.

The treatment consists of a single session and generates savings for the health system as well as for the affected persons and their families.

The earlier the care is sought, the greater the possibility for opting for this treatment alternative.

pll/npg/lpn

LATEST NEWS
RELATED